Daily SPAC Update – September 24, 2024

by | Sep 24, 2024

RFAC and NVAC Extensions Approved. MITA, NBST, TBMC, TMTC Extension Votes Today. IXAQ and FRLA Extension Votes Set.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
RFAC – RF ACQUISITION CORP * Extend to Mar 28, 2025 * 1,170,280 redeemed * trust $11.23
NVAC – NORTHVIEW ACQUISITION CORP * Extend to Mar 22, 2025 * 50,556 redeemed

SPAC DEAL & EXTENSION VOTES SET
IXAQ – Ix Acquisition Corp * EXTENSION VOTE SET: Oct 09, 2024 * trust $11.54
FRLA – Fortune Rise Acquisition Corp * EXTENSION VOTE SET: Oct 23, 2024 * trust $11.42

EXTENSION VOTES
MITA – COLISEUM ACQUISITION CORP * extend to December 25, 2024
NBST – NEWBURY STREET ACQUISITION CORP *  extend from September 25, 2024 to March 25, 2025
TBMC – TRAILBLAZER MERGER CORP I * extend to September 30, 2025
TMTC – TMT ACQUISITION CORP * extend to December 30, 2024

SPAC DEALS ANNOUNCED
Sep 20 | FTII – Futuretech Ii Acquisition Corp * + Longevity Biomedical, Inc.

SPAC DEAL TERMINATIONS (Last 10 Days)
2024-09-17: BACA + Custom Health, Inc

YESTERDAY’S TOP SPAC GAINERS
1.59% ~ $ 11.50 | ATEK – Athena Technology Acquisition Corp. II (Pre-Deal)
1.58% ~ $ 11.58 | MSSA – Metal Sky Acquisition Corp (Pre-Deal)
.98% ~ $ 11.34 | GLLI – Globalink Investment Inc. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-4.89% ~ $ 10.51 | IRAA – Tribe Capital Growth Corp I (Announced)
-4.67% ~ $ 11.03 | ACAB – Atlantic Coastal Acquisition Corp. II (Announced)
-4.17% ~ $ 11.02 | XFIN – ExcelFin Acquisition Corp. (Announced)
-3.35% ~ $ 11.68 | CLOE – Clover Leaf Capital Corp. (Announced)
-2.08% ~ $ 13.20 | ACAC – Acri Capital Acquisition Corp (Announced)

Recent Analysis

Daily SPAC Update – March 20, 2026

Another Quantum DeSPAC as DMY becomes Horizon Quantum. Inflection Point III Increases PIPE. UY Scuti Moves Vote Again. Blue Water IV IPOs for $125 Million.

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Daily SPAC Update – March 18, 2026

DMY Squared’s Quantum Deal Approved. Winvest Acquisition Extension Approved. Pelican Deal Vote Delayed. Alphatime Sets Extension Vote. Cayson Goes to Vote.

Daily SPAC Update – March 17, 2026

Harry You’s DMY Squared Deal Vote with Horizon Quantum Today. Pelican Acquisition Deal Vote. Abra and GNQ Insilico Deals Announced. Merlin DeSPAC.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.